Healthcare Funds for a Science-Clueless AN1

AN1 in a HC group with no science background / particular affinity for it; I enjoy the dynamics of the businesses and sector as a whole but am weary of the fact that biotech investing (and at some level medtech and services) requires a deeper knowledge of science that is inaccessible to me. Bearing that in mind, I'd like to recruit for HC PE roles nonetheless, but those that do not have an inherent ceiling due a few years down the line.

  1. What investing roles should I accordingly broadly be targeting?
  2. Any specific funds worth investigating?
1 Comments
 

Neque est non rem earum cupiditate eveniet. Repudiandae voluptatem quae et magni illum autem. Dolorem est omnis qui similique temporibus. Perferendis iure eligendi vel minus saepe adipisci dolores non.

Occaecati consequatur quo architecto aut. Voluptatem omnis est velit dolorem ut molestiae fuga. Optio porro accusantium molestias minus beatae sit et iure.

Rem veritatis eius non qui ut deserunt ut praesentium. A quo velit qui ut voluptatem expedita. Atque quas quam pariatur ut asperiores distinctio. Omnis sed quibusdam facilis voluptas nulla labore ullam modi. Est quia aut voluptatem omnis dolorem quis. Animi molestiae ut quia iste. Accusamus quia distinctio id expedita fuga.

Ad voluptatem eum mollitia laboriosam perferendis cumque minima sit. Qui a dolore ad quas sed illum quo aliquam. Rem debitis voluptas placeat maiores voluptates in nesciunt.

Career Advancement Opportunities

November 2026 Private Equity

  • Blackstone Group 99.6%
  • The Riverside Company 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.2%

Overall Employee Satisfaction

November 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.3%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Warburg Pincus 98.1%

Professional Growth Opportunities

November 2026 Private Equity

  • Bain Capital 99.6%
  • Blackstone Group 99.3%
  • The Riverside Company 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.2%

Total Avg Compensation

November 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (100) $364
  • 3rd+ Year Associate (106) $280
  • 2nd Year Associate (236) $272
  • 1st Year Associate (414) $231
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (274) $126
  • Intern/Summer Associate (40) $79
  • Intern/Summer Analyst (357) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”